Company intelligence
Global Colon Cancer Association
About Global Colon Cancer Association
The Global Colon Cancer Association is the voice for the millions of colon cancer (CRC) patients worldwide. We advocate for patient centered policy around the globe to ensure increased awareness and screening, access to quality medical treatments and help our member organizations collaborate, innovate and leverage the full potential of effectuating change. The GCCA also supports the creation of new patient advocacy groups in developing areas which have no CRC organizations. The GCCA unites all stakeholders in the battle against this disease with one unified voice. To learn more about Biomarkers, please visit : https://gcca.info/_Linkedin_ The Global Colon Cancer Association s a 501(c)3 not-for-profit organization with Tax ID No: 46-0657002
Verified activity
Signals from Global Colon Cancer Association
4 published signals
Presence & Recognition
Global Colon Cancer Association announced Dr. Apeksha P. Patel as a Global CRC Congress speaker at the 2026 Global CRC Congress.
Reported by Global Colon Cancer Association
Research & Knowledge
Global Colon Cancer Association published new results from the STAR-TREC trial, which found that long-course chemoradiotherapy was more likely than short-course radiotherapy to allow patients to avoid total mesorectal excision at 12 months among carefully selected people with early or intermediate-stage rectal cancer pursuing organ preservation.
Reported by Global Colon Cancer Association
Presence & Recognition
Global Colon Cancer Association announced that Helena Harnik, Programs Executive Director at The Synergist.org and Executive Director of the From Testing to Targeted Treatments (FT3) Program, will join the 2026 Global CRC Congress for conversations on improving colorectal cancer care and access.
Reported by Global Colon Cancer Association
Presence & Recognition
Global Colon Cancer Association hosted a webinar titled HER2 and Colorectal Cancer: What Advocates Need to Know featuring Dr. John Strickler discussing HER2-positive colorectal cancer prognosis and treatment guidance.
Reported by Global Colon Cancer Association